Ozempic: Reshaping Desire Since 2023

A DRUG INITIALLY approved for type 2 diabetes, and now widely used for weight loss, is forcing us to grapple with the age-old question of what it means to choose freely. Weight loss drugs that work by suppressing appetite are not new. Semaglutide, better known by its brand names Ozempic and Wegovy, just happens to be very good at it. So much so that the drug is single-handedly boosting the economy of Denmark, where its manufacturer Novo Nordisk is based.

Read Full Article »


Comment
Show comments Hide Comments


Related Articles